Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 17 of 123)
- Relevance
  Sort by

Neuroblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
308 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
138 Pages
Global

From

€1820EUR$2,000USD£1,560GBP

Gliosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
105 Pages
Global

From

€1820EUR$2,000USD£1,560GBP

Colorectal Cancer Therapeutics Market Report and Forecast 2023-2031

 Report
April 2023
160 Pages
Global

From

€4504EUR$4,949USD£3,861GBP

Latin America Melanoma Diagnostics and Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
100 Pages
Latin America

From

€4323EUR$4,750USD£3,706GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Liver Cancer Drugs Market 2024-2028

 Report
June 2024
142 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Anti-Obesity Therapeutics Market by Treatment Type (Medications, Treatments), Drug Type (Over-The-Counter Drugs, Prescription Drugs), Route Of Administration, Drug Formulation, End-User, Distribution Channel - Global Forecast 2025-2030

 Report
March 2025
193 Pages
Global

From

€3226EUR$3,545USD£2,766GBP

€3585EUR$3,939USD£3,073GBP

Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
574 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Schizophrenia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
185 Pages
Global

€4546EUR$4,995USD£3,897GBP

Bladder Cancer Treatment Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

 Report
October 2023
101 Pages
Global

From

€3500EUR$4,120USD£3,106GBP

Blood Brain Barrier Technologies Market Forecast to 2028 - COVID-19 Impact and Global Analysis

 Report
October 2021
157 Pages
Global

From

€4050EUR$4,450USD£3,472GBP

Aids Related Cancer Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
March 2022
80 Pages
Global

From

€3500EUR$4,120USD£3,106GBP

Vascular Endothelial Growth Factor (Vegf) Inhibitors Market 2024-2028

 Report
May 2024
178 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Vitiligo Therapeutics - Global Strategic Business Report

 Report
April 2025
192 Pages
Global

From

€5324EUR$5,850USD£4,564GBP

Atopic Dermatitis Drugs - Global Strategic Business Report

 Report
April 2025
179 Pages
Global

From

€5324EUR$5,850USD£4,564GBP

ADC Technology Market: Focus on ADC Linker and ADC Conjugation Technologies (2nd Edition) - Distribution by Generation of ADC Technology, Type of Conjugation, Type of Linker and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

 Report
July 2023
407 Pages
Global

From

€4368EUR$4,799USD£3,744GBP

Urothelial Carcinoma Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2023
91 Pages
Global

From

€3500EUR$4,120USD£3,106GBP

US Glioma - Market Insight, Epidemiology And Market Forecast - 2032

 Report
April 2023
200 Pages
United States

From

€3413EUR$3,750USD£2,926GBP

Glioma - Competitive Landscape, 2023

 Report
April 2023
450 Pages
Global

From

€2958EUR$3,250USD£2,536GBP

Cell Therapy Clinical Activity and Process Automation

 Report
July 2023
100 Pages
Global

From

€4414EUR$4,850USD£3,784GBP

2,452 Results (Page 17 of 123)
- 1
- 15
- 16
- 17
- 18
- 19

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.